American International Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,653
| Closed | -$838K | – | 1438 |
|
|
2024
Q1 | $838K | Buy |
12,653
+1,465
| +13% | +$97K | ﹤0.01% | 1395 |
|
|
2023
Q4 | $445K | Sell |
11,188
-45
| -0.4% | -$1.79K | ﹤0.01% | 1739 |
|
|
2023
Q3 | $358K | Buy |
11,233
+399
| +4% | +$12.7K | ﹤0.01% | 1797 |
|
|
2023
Q2 | $435K | Buy |
10,834
+1,547
| +17% | +$62.2K | ﹤0.01% | 1728 |
|
|
2023
Q1 | $397K | Buy |
9,287
+185
| +2% | +$7.9K | ﹤0.01% | 1734 |
|
|
2022
Q4 | $437K | Buy |
9,102
+560
| +7% | +$26.9K | ﹤0.01% | 1666 |
|
|
2022
Q3 | $321K | Buy |
8,542
+684
| +9% | +$25.7K | ﹤0.01% | 1856 |
|
|
2022
Q2 | $217K | Buy |
7,858
+110
| +1% | +$3.04K | ﹤0.01% | 2133 |
|
|
2022
Q1 | $421K | Sell |
7,748
-545
| -7% | -$29.6K | ﹤0.01% | 1817 |
|
|
2021
Q4 | $485K | Sell |
8,293
-248
| -3% | -$14.5K | ﹤0.01% | 1828 |
|
|
2021
Q3 | $338K | Sell |
8,541
-203
| -2% | -$8.03K | ﹤0.01% | 2097 |
|
|
2021
Q2 | $371 | Buy |
8,744
+1,013
| +13% | +$43 | ﹤0.01% | 2118 |
|
|
2021
Q1 | $476 | Buy |
7,731
+150
| +2% | +$9 | ﹤0.01% | 1870 |
|
|
2020
Q4 | $535 | Buy |
7,581
+3,416
| +82% | +$241 | ﹤0.01% | 1707 |
|
|
2020
Q3 | $161K | Sell |
4,165
-96
| -2% | -$3.71K | ﹤0.01% | 2267 |
|
|
2020
Q2 | $160K | Buy |
+4,261
| New | +$160K | ﹤0.01% | 2256 |
|